- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01577719
South Asian HeArt Risk Assessment Project - Pilot (SAHARA-Pilot)
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Introduction: Coronary heart disease (CHD) remains the major cause of disease burden globally, and the rising prevalence of overweight, obesity and adult onset diabetes is predicted to potentiate the CHD epidemic in developing countries, and in high risk populations, including people who originate from the Indian subcontinent (South Asians). More than 1.2 million people of South Asian origin live in Canada and they are the fastest growing group of non-white Canadians. Our previous work among South Asians has shown that, compared to white Caucasians in Canada, they suffer from a 2.5 times excess prevalence of elevated glucose (dysglycemia), and CHD. They also develop abnormal glucose, lipids (elevated apolipoprotein B & reduced apolipoprotein Al) and blood pressure at significantly lower body mass index values compared to white Caucasians (21 vs. 30). Successful interventions which prevent or improve myocardial infarction (MI) risk factors among South Asians are urgently needed.
Objectives: Among South Asian men and women ≥ 30 years who live in Canada we propose:
- To test the effectiveness of a culturally-tailored multimedia intervention designed to improve health behaviours including dietary habits, sedentary behaviours, physical activity, and tobacco use, in order to improve their MI risk factor profile.
- To test if knowledge of genetic risk for MI as determined by the 9p21 variant genotype influences behaviour change and MI risk factor profile.
- To determine the change in the MI risk score and clinical events including MI, death, development of new diabetes, and development of new hypertension over the 6 months follow-up.
Design & Methods: People of South Asian ancestry defined as people whose ancestors originate from the Indian subcontinent (India, Pakistan, Bangladesh and Sri Lanka) ≥ 30 years age will be eligible for SAHARA. Subjects with no access to e-mail, text messaging or smart phones and who have suffered previous coronary heart disease will be excluded. 400 subjects will undergo a brief cardiac risk factor assessment including collection of data on questionnaire, physical measurement (i.e. weight, height, waist and hip circumference, and blood pressure), and a blood sample will be collected to measure apolipoproteins and glucose. All eligible and consenting subjects will be randomized 1:1 to intervention versus control. The intervention group will include goal setting, self monitoring and participants will receive regular health messaging using electronic media regarding smoking, dietary habits & physical activity. The control group will receive usual advice and no regular health messaging. The intervention will last for 6 months after and the effectiveness of this intervention will be evaluated using the change in the cardiac risk score after 6 months.
Summary: South Asians are the fastest growing group of Canadians. They suffer an excess prevalence of cardiac risk factors and MI at a younger age compared to people of European origin. The SAHARA project will enable us to use simple but validated tools to assess the MI risk profile among South Asian men and women from Ontario, and we will test a culturally-tailored multimedia intervention to determine if improvement in the MI risk factor profile can be achieved and sustained. If this intervention is successful it will be easily scalable, and has the potential to be delivered to a large proportion of the South Asian community in Canada.
Study Type
Enrollment (Anticipated)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Ontario
-
Hamilton, Ontario, Canada, L8L 2X2
- Population Health Research Institute
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- South Asian Ancestry (originating from India, Pakistan, Bangladesh and Sri Lanka);
- Greater than or equal to 30 years of age;
- No previous cardiovascular disease
Exclusion Criteria:
- Not residents of Ontario
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Placebo Comparator: Usual Care
usual care
|
Participant will be refered to SAHARA study website to get information on healthy lifestyle and to get regular update for the course of follow-up.
|
|
Active Comparator: Multimedia Lifestyle Improvement
Multimedia lifestyle intervention
|
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Effectiveness of a 6 month culturally-specific multi-media intervention on Heart Health Risk
Time Frame: Baseline and at 6 months from randomization
|
To test the effectiveness of a 6 month culturally-specific multi-media intervention which provides health messaging and feedback regarding optimal strategies for individuals greater than 30 years to improve their dietary habits, sedentary behaviours, physical activity, and tobacco use.
|
Baseline and at 6 months from randomization
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Influence of knowledge of personal genetic risk for Myocardial Infarction on health behaviours
Time Frame: Baseline and at 6 months from randomization
|
To determine if knowledge of personal genetic risk for Myocardial Infarction (MI)and Diabetes influences the health behaviours associated with MI risk factors.
|
Baseline and at 6 months from randomization
|
|
Change in the MI risk score and clinical events
Time Frame: Baseline and at 6 months from randomization
|
To determine the change in the MI risk score and clinical events including MI, death, development of new diabetes, and development of new hypertension over time in all people screened for entry into the randomized intervention.
|
Baseline and at 6 months from randomization
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Sonia Anand, MD, PhD, McMaster University; Hamilton Health Sciences; Population Health Research Institute
Publications and helpful links
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- SAHARA-Pilot
- NA 6865 (Other Grant/Funding Number: Heart and Stroke Foundation of Ontario)
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Cardiovascular Diseases
-
Weill Medical College of Cornell UniversityAmerican Heart AssociationRecruitingCardiovascular | Cardiovascular Health | Cardiovascular (CV) Risk | Cardiovascular Disease (CVD) Risk FactorsUnited States
-
Hull University Teaching Hospitals NHS TrustNot yet recruitingCardiovascular Surgery | Cardiovascular Diseases (CVD)United Kingdom
-
Fu Jen Catholic UniversityRecruitingCardiovascular Disease | Cardiovascular SurgeryTaiwan
-
Medical College of WisconsinNational Center for Complementary and Integrative Health (NCCIH)CompletedCardiovascular Diseases | Cardiovascular Risk Factor | Cardiovascular HealthUnited States
-
Hospital Mutua de TerrassaCompleted
-
IRCCS Policlinico S. DonatoIRCCS San Raffaele; Fondazione Policlinico Universitario Agostino Gemelli IRCCS and other collaboratorsRecruitingCardiovascular Risk | Genetic Cardiovascular RiskItaly
-
Oregon Health and Science UniversityCompletedCardiovascular Disease | Cardiovascular Risk FactorsUnited States
-
Women's College HospitalUniversity Health Network, Toronto; Sunnybrook Health Sciences Centre; Brigham... and other collaboratorsUnknownCARDIOVASCULAR DISEASESCanada, United States
-
Groupe Hospitalier Paris Saint JosephTerminatedCARDIOVASCULAR DISEASESFrance
-
Children's Hospital Medical Center, CincinnatiRecruitingCardiovascular Diseases (CVD)United States
Clinical Trials on Multimedia Lifestyle Improvement
-
McMaster UniversityUnknownCardiovascular Diseases | Diabetes | Abdominal ObesityCanada
-
Federal University of São PauloFundação de Amparo à Pesquisa do Estado de São Paulo; Conselho Nacional de... and other collaboratorsCompleted
-
Marmara UniversityRecruitingAnxiety State | Undescended TestisTurkey
-
David Grant U.S. Air Force Medical CenterCompletedPrimary Prevention
-
University of SheffieldEthicon Endo-Surgery; HCA International Limited; DigimedCompletedFocus of Study: Cognitive Surgical Skill AcquisitionUnited Kingdom
-
Changzhou No.2 People's HospitalRecruitingAnxiety | Vitreous FloatersChina
-
Akdeniz UniversityCompleted
-
Chang Gung Memorial HospitalCompletedQuality of Life | Enterostomy | Self-care | Multimedia Learning EducationTaiwan
-
Michigan Technological UniversityCompletedKnowledge, Attitudes, PracticeUnited States
-
Kanuni Sultan Suleyman Training and Research HospitalCompletedAnxiety | Abnormal Uterine BleedingTurkey